Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

SNIP1 Activators

SNIP1 Activators encompass a diverse set of chemical compounds that indirectly potentiate the functional activity of SNIP1 through multifaceted signaling pathways. For instance, Forskolin, by increasing cAMP levels, indirectly augments SNIP1's transcriptional regulation by facilitating PKA-mediated phosphorylation. Similarly, Rolipram and Zaprinast elevate intracellular cAMP and cGMP concentrations, respectively, leading to PKA activation which can phosphorylate and enhance SNIP1 activity. The differential kinase inhibition by Epigallocatechin gallate and Genistein can lessen the phosphorylation of competing transcriptional regulators, thereby indirectly potentiating SNIP1's regulatory functions. The modulation of calcium signaling with compounds like Ionophore A23187 and Thapsigargin can trigger the activation of calcium-dependent kinases that might contribute to the phosphorylation and subsequent enhancement of SNIP1's functional role. Furthermore, the activation of PKC by PMA could lead to a cascade of phosphorylation events benefiting SNIP1's transcriptional activities.

Alterations in intracellular signaling pathways by specific such as LY294002, U0126, and SB203580 indirectly facilitate SNIP1 activation. LY294002's inhibition of PI3K, U0126's targeting of MEK1/2, and SB203580's blockade of p38 MAPK can shift cellular signaling dynamics, thereby enhancing pathways that relyon SNIP1's involvement. The selective inhibition of these pathways allows for a compensatory increase in the activities where SNIP1 is a critical mediator, such as in transcriptional regulation. Additionally, the lipid signaling modulator Sphingosine-1-phosphate can enhance SNIP1 activity by engaging in signaling cascades that ultimately potentiate transcriptional regulation processes. Collectively, these SNIP1 Activators operate through a series of intracellular modifications and kinase interactions, leading to an upsurge in SNIP1's activity without directly increasing its expression levels or requiring direct activators, ensuring that SNIP1's regulatory functions are amplified within the cell.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin activates adenylate cyclase, which increases cAMP levels in cells. Elevated cAMP activates PKA, which can phosphorylate SNIP1, enhancing its activity in its role as a transcriptional regulator.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$43.00
$73.00
$126.00
$243.00
$530.00
$1259.00
11
(1)

EGCG inhibits a range of kinases, thereby potentially reducing the phosphorylation of proteins that may compete with SNIP1 for binding to transcriptional machinery, thus indirectly enhancing SNIP1 activity.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$55.00
$131.00
$203.00
$317.00
23
(1)

The calcium ionophore A23187 increases intracellular calcium concentration. Increased calcium can activate calmodulin-dependent kinases which can phosphorylate SNIP1, thereby enhancing its functional activity.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA activates protein kinase C (PKC) which can lead to the phosphorylation of transcriptional regulators. This may enhance SNIP1's ability to interact with other proteins and DNA, increasing its activity.

D-erythro-Sphingosine-1-phosphate

26993-30-6sc-201383
sc-201383D
sc-201383A
sc-201383B
sc-201383C
1 mg
2 mg
5 mg
10 mg
25 mg
$165.00
$322.00
$570.00
$907.00
$1727.00
7
(1)

Sphingosine-1-phosphate receptor activation can lead to a cascade effect that activates MAPK and AKT signaling pathways, which can enhance SNIP1's transcription regulatory functions.

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$77.00
$216.00
18
(1)

Rolipram inhibits phosphodiesterase 4, thereby preventing cAMP degradation. Higher cAMP levels lead to activation of PKA, which can enhance SNIP1's activity by phosphorylation.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor, which can alter the PI3K/AKT pathway. This alteration can shift cellular balance towards pathways where SNIP1 is active, thus indirectly enhancing its activity.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is a p38 MAPK inhibitor. Inhibition of p38 MAPK can result in the redirection of cellular signaling towards pathways where SNIP1 functions are required, thereby potentially enhancing its activity.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

Genistein is a tyrosine kinase inhibitor. By inhibiting competitive signaling routes, it may enhance SNIP1's role in transcription regulation due to reduced competitive inhibition.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Thapsigargin disrupts calcium homeostasis, which can lead to the activation of signaling pathways involving calcium-dependent kinases that can phosphorylate and enhance SNIP1 activity.